** Shares of Biome Australia BIO.AX up 6.6% at A$0.485
** Stock rises as much as 7.7%, hits its highest level since May 6
** Biotherapeutics firm posts sales revenue of ~A$18.4 million (~$12.10 million) for FY25, up 41% from FY24
** BIO anticipates reporting another quarter of positive EBITDA for Q4 and its inaugural full year of net profit in the FY25 accounts
** About 346,500 shares change hands, 1.2x 30-day average vol.
** Stock down 22.9% this year, as of last close
($1 = 1.5207 Australian dollars)
(Reporting by Sherin Sunny in Bengaluru)
((Sherin.Sunny@thomsonreuters.com))